Vancouver, Canada--(Newsfile Corp. - January 29, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today announced that Mr. Mike Kelly, President & CEO, will be participating in a fireside chat...
Goldman Sachs issues surprising gold price target for 2025 The investment firm's analysts share their views about the precious metal. TSLA Investing News, Analysis, and Tips Feb 21, 2025 10:13 AM EST UnitedHealth stock plunges on report of DoJ Medicare Advantage probe ...